Jianjian Zhao1, Lei Peng2, Zheng Luo2, Ruibing Cui2, Ming Yan2. 1. Department of Geriatric Gastroenterology, Qilu Hospital of Shandong University Jinan, Shandong, China ; Key Laboratory of Cardiovascular Remodeling, Qilu Hospital of Shandong University Jinan, Shandong, China. 2. Department of Geriatric Gastroenterology, Qilu Hospital of Shandong University Jinan, Shandong, China.
Abstract
AIM: The activation of Hepatic stellate cell (HSC) is a pivotal event in the initiation and progression of hepatic fibrosis and a major source of collagen deposition. A recent study found that autophagy fuels the HSC activation. α-ketoglutarate (AKG), an intermediate in the Kerbs CYCLE, has been shown to regulate the level of autophagy. In this study, we aim to investigate the potential effect of dimethyl α-ketoglutarate (DMKG), a membrane-permeable esters of AKG, on the activation of HSC. METHODS: HSC and hepatocyte cell lines were treated with DMKG at gradient concentrations, MTT assay was used to assess the cell viability. Concentrations of DMKG that did not affect the cell survival were added to the culture media of HSC cells. Real-time PCR and western blot analysis was carried out to evaluate the expression of fibrogenic genes in HSC after culture for 24 hours. RESULTS: Low dose of DMKG had little cytotoxicity to both HSCs and hepatocytes, while HSCs were more vulnerable to high dose of DMKG than hepatocytes. More importantly, DMKG inhibited the expression of α-SMA and collagen I significantly in HSCs detected by real-time PCR and western blot analysis at the concentrations that didn't decrease cell viability. CONCLUSIONS: DMKG has a significant role of inhibiting the activation of HSC and may attenuate hepatic fibrosis safely.
AIM: The activation of Hepatic stellate cell (HSC) is a pivotal event in the initiation and progression of hepatic fibrosis and a major source of collagen deposition. A recent study found that autophagy fuels the HSC activation. α-ketoglutarate (AKG), an intermediate in the Kerbs CYCLE, has been shown to regulate the level of autophagy. In this study, we aim to investigate the potential effect of dimethyl α-ketoglutarate (DMKG), a membrane-permeable esters of AKG, on the activation of HSC. METHODS: HSC and hepatocyte cell lines were treated with DMKG at gradient concentrations, MTT assay was used to assess the cell viability. Concentrations of DMKG that did not affect the cell survival were added to the culture media of HSC cells. Real-time PCR and western blot analysis was carried out to evaluate the expression of fibrogenic genes in HSC after culture for 24 hours. RESULTS: Low dose of DMKG had little cytotoxicity to both HSCs and hepatocytes, while HSCs were more vulnerable to high dose of DMKG than hepatocytes. More importantly, DMKG inhibited the expression of α-SMA and collagen I significantly in HSCs detected by real-time PCR and western blot analysis at the concentrations that didn't decrease cell viability. CONCLUSIONS: DMKG has a significant role of inhibiting the activation of HSC and may attenuate hepatic fibrosis safely.
Authors: Virginia Hernández-Gea; Zahra Ghiassi-Nejad; Raphael Rozenfeld; Ronald Gordon; Maria Isabel Fiel; Zhenyu Yue; Mark J Czaja; Scott L Friedman Journal: Gastroenterology Date: 2012-01-10 Impact factor: 22.682
Authors: Raúl V Durán; Wolfgang Oppliger; Aaron M Robitaille; Lisa Heiserich; Roswitha Skendaj; Eyal Gottlieb; Michael N Hall Journal: Mol Cell Date: 2012-06-29 Impact factor: 17.970
Authors: Yuqing Liu; Zhuo Wang; Shu Qin Kwong; Eric Lik Hang Lui; Scott L Friedman; Fu Rong Li; Reni Wing Chi Lam; Guo Chao Zhang; Hui Zhang; Tao Ye Journal: J Hepatol Date: 2011-01-18 Impact factor: 25.083
Authors: Ashton Faulkner; Anita Tamiato; William Cathery; Andrea Rampin; Carlo Maria Caravaggi; Eva Jover; Steve Allen; Harry Mellor; David Hauton; Lisa C Heather; Gaia Spinetti; Paolo Madeddu Journal: Diabetologia Date: 2020-07-30 Impact factor: 10.122